Pamela F Weiss Selected Research

chlorotriphenylsilane (CTPS)

10/2021	Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
4/2017	Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
7/2014	Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pamela F Weiss Research Topics

Disease

16	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 09/2012
7	Arthritis (Polyarthritis) 05/2022 - 09/2012
5	Sacroiliitis 01/2021 - 05/2015
5	Pain (Aches) 10/2020 - 11/2007
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2018
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 02/2016
3	Uveitis 09/2020 - 09/2012
3	Purpura 10/2010 - 11/2007
2	Ankylosing Spondylitis 04/2022 - 06/2012
2	Osteomyelitis 01/2022 - 01/2021
2	Fibromyalgia (Fibrositis) 01/2019 - 09/2015
2	Iritis 02/2016 - 02/2016
2	Tuberculosis (Tuberculoses) 10/2013 - 10/2013
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2022
1	Necrosis 05/2022
1	Joint Diseases (Joint Disease) 05/2022
1	Genetic Risk Score 04/2022
1	Lupus Nephritis 01/2022
1	Nephritis 01/2022
1	Proteinuria 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Musculoskeletal Pain 01/2019
1	Neuromyelitis Optica (Devic's Disease) 04/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Reactive Arthritis (Reiter Disease) 01/2018
1	Vasculitis (Vasculitides) 01/2017
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2017
1	Dermatomyositis (Dermatopolymyositis) 01/2017
1	Histiocytosis 12/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2015
1	Edema (Dropsy) 05/2015
1	Spondylarthropathies 02/2014
1	Psoriatic Arthritis 09/2012
1	Rheumatoid Arthritis 06/2012
1	Thrombotic Thrombocytopenic Purpura 01/2012
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2012
1	Myasthenia Gravis 01/2012
1	Angioedema 05/2011
1	Eosinophilic Fasciitis 05/2011
1	Acute Disease 04/2008
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2008
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2008
1	Abdominal Pain (Pain, Abdominal) 11/2007
1	Intussusception 11/2007

Drug/Important Bio-Agent (IBA)

9	Biological ProductsIBA 01/2022 - 06/2012
8	Tumor Necrosis Factor InhibitorsIBA 05/2022 - 09/2012
6	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2022 - 02/2014
6	GlucocorticoidsIBA 01/2022 - 02/2016
6	Antirheumatic Agents (DMARD)IBA 01/2022 - 06/2012
3	chlorotriphenylsilane (CTPS)IBA 10/2021 - 07/2014
3	Infliximab (Remicade)FDA Link 01/2021 - 05/2011
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2016 - 12/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2010 - 11/2007
2	Adalimumab (Humira)FDA Link 01/2021 - 09/2019
2	Etanercept (Enbrel)FDA Link 01/2021 - 09/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019 - 01/2018
2	GadoliniumIBA 12/2016 - 05/2015
2	Monoclonal AntibodiesIBA 02/2016 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 12/2015 - 09/2012
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	ixekizumabIBA 01/2022
1	secukinumabIBA 01/2022
1	Certolizumab Pegol FDA Link 01/2022
1	golimumab FDA Link 01/2021
1	A 7 (A-7)IBA 09/2020
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 04/2018
1	Cytidine Triphosphate (CTP)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Particulate MatterIBA 09/2016
1	C-Reactive ProteinIBA 02/2016
1	Pharmaceutical PreparationsIBA 10/2015
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	Rheumatoid FactorIBA 09/2012
1	AntibodiesIBA 09/2012
1	Interleukin-1 (Interleukin 1)IBA 09/2012
1	thiamine triphosphorate (TTP)IBA 01/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 11/2007
2	Arthroplasty 02/2016 - 02/2016
2	Physical Therapy Modalities (Physical Therapy Technique) 02/2016 - 02/2016
1	Pain Management 05/2022
1	Polypharmacy 01/2019
1	Injections 01/2018
1	Occupational Therapy (Therapy, Occupational) 09/2015